• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒感染和疫苗接种均可诱导对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株产生高亲和力的跨谱系反应。

Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants.

作者信息

Emmenegger Marc, Fiedler Sebastian, Brugger Silvio D, Devenish Sean R A, Morgunov Alexey S, Ilsley Alison, Ricci Francesco, Malik Anisa Y, Scheier Thomas, Batkitar Leyla, Madrigal Lidia, Rossi Marco, Meisl Georg, Lynn Andrew K, Saleh Lanja, von Eckardstein Arnold, Knowles Tuomas P J, Aguzzi Adriano

机构信息

Institute of Neuropathology, University of Zurich, 8091 Zurich, Switzerland.

Fluidic Analytics, Unit A, The Paddocks Business Centre, Cherry Hinton Road, Cambridge CB1 8DH, UK.

出版信息

iScience. 2022 Aug 19;25(8):104766. doi: 10.1016/j.isci.2022.104766. Epub 2022 Jul 16.

DOI:10.1016/j.isci.2022.104766
PMID:35875683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9288251/
Abstract

The B.1.1.529 (omicron) variant has rapidly supplanted most other SARS-CoV-2 variants. Using microfluidics-based antibody affinity profiling (MAAP), we have characterized affinity and IgG concentration in the plasma of 39 individuals with multiple trajectories of SARS-CoV-2 infection and/or vaccination. Antibody affinity was similar against the wild-type, delta, and omicron variants ( ranges: 122 ± 155, 159 ± 148, 211 ± 307 μM, respectively), indicating a surprisingly broad and mature cross-clade immune response. Postinfectious and vaccinated subjects showed different IgG profiles, with IgG3 (p-value = 0.002) against spike being more prominent in the former group. Lastly, we found that the ELISA titers correlated linearly with measured concentrations (R = 0.72) but not with affinity (R = 0.29). These findings suggest that the wild-type and delta spike induce a polyclonal immune response capable of binding the omicron spike with similar affinity. Changes in titers were primarily driven by antibody concentration, suggesting that B-cell expansion, rather than affinity maturation, dominated the response after infection or vaccination.

摘要

B.1.1.529(奥密克戎)变种已迅速取代了大多数其他严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变种。我们使用基于微流控的抗体亲和力分析(MAAP),对39名有多种SARS-CoV-2感染和/或疫苗接种轨迹的个体血浆中的亲和力和IgG浓度进行了表征。针对野生型、德尔塔和奥密克戎变种的抗体亲和力相似(范围分别为:122±155、159±148、211±307μM),表明存在令人惊讶的广泛且成熟的跨分支免疫反应。感染后和接种疫苗的受试者表现出不同的IgG谱,其中针对刺突蛋白的IgG3(p值 = 0.002)在前一组中更为突出。最后,我们发现酶联免疫吸附测定(ELISA)滴度与测量浓度呈线性相关(R = 0.72),但与亲和力无关(R = 0.29)。这些发现表明,野生型和德尔塔刺突蛋白诱导了一种能够以相似亲和力结合奥密克戎刺突蛋白的多克隆免疫反应。滴度变化主要由抗体浓度驱动,这表明B细胞扩增而非亲和力成熟在感染或接种疫苗后的反应中占主导地位。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c9c/9352531/3e3d27117fc4/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c9c/9352531/43d1cea03f61/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c9c/9352531/c4d8c255051c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c9c/9352531/b5ff38563004/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c9c/9352531/4b7ae3152bf7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c9c/9352531/1d0fc59550d2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c9c/9352531/3e3d27117fc4/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c9c/9352531/43d1cea03f61/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c9c/9352531/c4d8c255051c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c9c/9352531/b5ff38563004/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c9c/9352531/4b7ae3152bf7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c9c/9352531/1d0fc59550d2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c9c/9352531/3e3d27117fc4/gr5.jpg

相似文献

1
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants.新冠病毒感染和疫苗接种均可诱导对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株产生高亲和力的跨谱系反应。
iScience. 2022 Aug 19;25(8):104766. doi: 10.1016/j.isci.2022.104766. Epub 2022 Jul 16.
2
Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing.野生型 SARS-CoV-2 中和抗体的免疫活性会随着时间推移和变异株的不同而降低,但与诊断检测有很好的相关性。
Front Immunol. 2023 Feb 8;14:1055429. doi: 10.3389/fimmu.2023.1055429. eCollection 2023.
3
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.一种基于三聚体 RBD 的马赛克型 COVID-19 疫苗候选物可诱导针对奥密克戎和其他 SARS-CoV-2 变体的强大中和作用。
Elife. 2022 Aug 25;11:e78633. doi: 10.7554/eLife.78633.
4
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination.感染或接种疫苗后针对 SARS-CoV-2 奥密克戎变异株的抗体亲合力和中和反应。
J Immunol Res. 2022 Aug 31;2022:4813199. doi: 10.1155/2022/4813199. eCollection 2022.
5
Dynamics of Different Classes and Subclasses of Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants after Coronavirus Disease 2019 and CoronaVac Vaccination in Thailand.泰国新冠肺炎和科兴疫苗接种后对严重急性呼吸综合征冠状病毒 2 变异株不同类别和亚类抗体反应的动态。
mSphere. 2023 Feb 21;8(1):e0046522. doi: 10.1128/msphere.00465-22. Epub 2023 Jan 23.
6
Infection and Vaccine Induced Spike Antibody Responses Against SARS-CoV-2 Variants of Concern in COVID-19-Naïve Children and Adults.感染和疫苗诱导的针对 COVID-19 初治儿童和成人中关注的 SARS-CoV-2 变异株的 Spike 抗体反应。
J Clin Immunol. 2023 Nov;43(8):1706-1723. doi: 10.1007/s10875-023-01540-5. Epub 2023 Jul 5.
7
A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株德尔塔迅速被奥密克戎取代:新冠病毒疾病病例数出现前所未有的激增,住院人数减少,上呼吸道病毒载量相当。
medRxiv. 2022 Jan 28:2022.01.26.22269927. doi: 10.1101/2022.01.26.22269927.
8
Analysis of a SARS-CoV-2 convalescent cohort identified a common strategy for escape of vaccine-induced anti-RBD antibodies by Beta and Omicron variants.对 SARS-CoV-2 恢复期患者队列的分析表明,β和奥密克戎变异株通过共同策略逃避了疫苗诱导的针对 RBD 的抗体。
EBioMedicine. 2022 Jun;80:104025. doi: 10.1016/j.ebiom.2022.104025. Epub 2022 May 6.
9
Progress of the COVID-19: Persistence, Effectiveness, and Immune Escape of the Neutralizing Antibody in Convalescent Serum.新型冠状病毒肺炎进展:康复期血清中和抗体的持久性、有效性及免疫逃逸
Pathogens. 2022 Dec 13;11(12):1531. doi: 10.3390/pathogens11121531.
10
Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.COVID-19 患者在突破感染 SARS-CoV-2 变异株 Delta、Omicron-BA.1 和 Omicron-BA.5 期间的免疫反应。
Front Immunol. 2023 Jul 13;14:1150667. doi: 10.3389/fimmu.2023.1150667. eCollection 2023.

引用本文的文献

1
Antibody Avidity Maturation Following Booster Vaccination with an Intranasal Adenovirus Salnavac Vaccine.鼻内腺病毒疫苗Salnavac加强免疫后抗体亲和力成熟
Vaccines (Basel). 2024 Dec 2;12(12):1362. doi: 10.3390/vaccines12121362.
2
Biochemical rationale for transfusion of high titre COVID-19 convalescent plasma.高滴度 COVID-19 恢复期血浆输注的生化原理。
Sci Rep. 2024 Oct 9;14(1):23579. doi: 10.1038/s41598-024-75093-x.
3
The ASC inflammasome adapter governs SAA-derived protein aggregation in inflammatory amyloidosis.

本文引用的文献

1
Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentration.血清指纹将治疗性抗体的抗病毒活性与其亲和力和浓度联系起来。
Sci Rep. 2022 Nov 17;12(1):19791. doi: 10.1038/s41598-022-22214-z.
2
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses.针对 SARS 样病毒的多样化人类保护性广谱中和抗体的靶向分离。
Nat Immunol. 2022 Jun;23(6):960-970. doi: 10.1038/s41590-022-01222-1. Epub 2022 Jun 2.
3
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost.
ASC 炎症小体衔接蛋白调控炎症性淀粉样变性中的 SAA 衍生蛋白聚集。
EMBO Mol Med. 2024 Sep;16(9):2024-2042. doi: 10.1038/s44321-024-00107-0. Epub 2024 Jul 30.
4
Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2.微流控扩散粒径分析(MDS)测量针对 SARS-CoV-2 的分泌中和抗体亲和力。
Ann Biomed Eng. 2024 Jun;52(6):1653-1664. doi: 10.1007/s10439-024-03478-0. Epub 2024 Mar 8.
5
Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD20 therapy.反复接种 SARS-CoV-2 疫苗后微流控抗体分析显示,在接受抗 CD20 治疗的患者中,抗体亲和力和浓度与免疫受损和变异逃逸有关。
Front Immunol. 2024 Jan 8;14:1296148. doi: 10.3389/fimmu.2023.1296148. eCollection 2023.
6
Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections.既往免疫会限制黏膜抗体对 SARS-CoV-2 的识别,以及突破感染期间的 Fc 特征。
JCI Insight. 2023 Sep 22;8(18):e172470. doi: 10.1172/jci.insight.172470.
7
Indirect Dispersion of SARS-CoV-2 Live-Attenuated Vaccine and Its Contribution to Herd Immunity.严重急性呼吸综合征冠状病毒2减毒活疫苗的间接传播及其对群体免疫的贡献。
Vaccines (Basel). 2023 Mar 14;11(3):655. doi: 10.3390/vaccines11030655.
8
Protocol to determine antibody affinity and concentration in complex solutions using microfluidic antibody affinity profiling.使用微流控抗体亲和分析技术测定复杂溶液中的抗体亲和力和浓度的方案。
STAR Protoc. 2023 Mar 17;4(1):102095. doi: 10.1016/j.xpro.2023.102095. Epub 2023 Feb 13.
9
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region.对欧洲一个大型都市地区的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)血清流行率进行持续的人群水平监测。
iScience. 2023 Feb 17;26(2):105928. doi: 10.1016/j.isci.2023.105928. Epub 2023 Jan 4.
10
Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentration.血清指纹将治疗性抗体的抗病毒活性与其亲和力和浓度联系起来。
Sci Rep. 2022 Nov 17;12(1):19791. doi: 10.1038/s41598-022-22214-z.
接种 SARS-CoV-2 mRNA 加强针后,记忆 B 细胞的效力和广度增加。
Nature. 2022 Jul;607(7917):128-134. doi: 10.1038/s41586-022-04778-y. Epub 2022 Apr 21.
4
Functional and structural modifications of influenza antibodies during pregnancy.孕期流感抗体的功能和结构改变
iScience. 2022 Mar 16;25(4):104088. doi: 10.1016/j.isci.2022.104088. eCollection 2022 Apr 15.
5
Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2.微流控抗体亲和分析揭示记忆再激活和交叉反应在防御 SARS-CoV-2 中的作用。
ACS Infect Dis. 2022 Apr 8;8(4):790-799. doi: 10.1021/acsinfecdis.1c00486. Epub 2022 Mar 30.
6
Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike.SARS-CoV-2 感染而非稳定 Spike 疫苗接种可增强对地方性冠状病毒的交叉反应性抗体
Elife. 2022 Mar 15;11:e75228. doi: 10.7554/eLife.75228.
7
Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers.肿瘤 B 细胞相互作用通过上调三阴性乳腺癌中的 IL-10 促进同种型转换为免疫抑制性 IgG4 抗体反应。
J Transl Med. 2022 Mar 7;20(1):112. doi: 10.1186/s12967-022-03319-5.
8
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant.mRNA-1273 和 BNT162b2 mRNA 疫苗对 SARS-CoV-2 奥密克戎变异株的中和活性降低。
Cell Rep Med. 2022 Jan 24;3(2):100529. doi: 10.1016/j.xcrm.2022.100529. eCollection 2022 Feb 15.
9
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2.人血管紧张素转化酶 2 与奥密克戎和德尔塔 SARS-CoV-2 刺突 RBD 的受体结合和复合物结构。
Cell. 2022 Feb 17;185(4):630-640.e10. doi: 10.1016/j.cell.2022.01.001. Epub 2022 Jan 6.
10
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.严重急性呼吸综合征冠状病毒2型奥密克戎变异株B.1.1.529可导致广泛的中和抗体反应逃逸。
Cell. 2022 Feb 3;185(3):467-484.e15. doi: 10.1016/j.cell.2021.12.046. Epub 2022 Jan 4.